Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Ionis Pharmaceuticals, Inc. (Ionis)9.9M85.98%
Affini-T Therapeutics, Inc. (Affini-T)1.61M14.02%
Region
Currency:USD
2022/FY
Stock NameRevenueRatio
United States17.2M100.00%